NEOGENOMICS INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| CARDOZA GEORGE | President, Pharma Services | Award / Grant | 7,571 | — | — | 333,402 | Mar 2, 2020 |
| SHOVLIN ROBERT J. | President, Clinical Services | Tax Withholding | 810 | — | — | 144,830 | Mar 2, 2020 |
| Weiss Lawrence Martin | Chief Medical Officer | Award / Grant | 5,824 | — | — | 11,717 | Mar 2, 2020 |
| VAN OORT DOUGLAS M | Chairman and CEO | Tax Withholding | 2,353 | — | — | 2,281,128 | Mar 2, 2020 |
| McKenzie Kathryn B | Chief Financial Officer | Tax Withholding | 168 | — | — | 2,105 | Mar 2, 2020 |
| JONES STEVEN C | — | Option Exercise | 100,000 | $4.78 | $478,000 | 1,625,000 | Dec 30, 2019 |
| McKenzie Kathryn B | Chief Accounting Officer | Sale | 8,000 | $26.37 | $210,960 | 2,273 | Dec 10, 2019 |
| JONES STEVEN C | — | Gift | 50,000 | $24.53 | $1,226,500 | 195,234 | Nov 20, 2019 |
| VAN OORT DOUGLAS M | Chairman and CEO | Sale | 187,500 | $24.08 | $4,515,000 | — | Nov 19, 2019 |
| BALLIET JENNIFER | VP and Chief Culture Officer | Option Exercise | 166 | $8.03 | $1,333 | 29,695 | Nov 15, 2019 |
| CARDOZA GEORGE | President, Pharma Services | Sale | 19,444 | $23.15 | $450,129 | 325,831 | Nov 12, 2019 |
| VAN OORT DOUGLAS M | Chairman and CEO | Tax Withholding | 6,090 | — | — | 2,010,499 | Nov 8, 2019 |
| CARDOZA GEORGE | President, Pharma Services | Option Exercise | 55,556 | $7.15 | $397,225 | 356,387 | Nov 6, 2019 |
| Johnson Kevin C | — | Option Exercise | 6,666 | $7.27 | $48,462 | 49,951 | Oct 31, 2019 |
| SHOVLIN ROBERT J. | President, Clinical Services | Sale | 70,473 | $23.11 | $1,628,631 | 181,441 | Oct 31, 2019 |
| HANNAH ALISON L. | — | Option Exercise | 8,333 | $9.11 | $75,914 | 76,098 | Sep 9, 2019 |
| JONES STEVEN C | — | Gift | 3,400 | — | — | 43,057 | Sep 6, 2019 |
| JONES STEVEN C | — | Sale | 39,537 | $25.02 | $989,216 | 1,679,124 | Aug 30, 2019 |
| VAN OORT DOUGLAS M | Chairman and CEO | Gift | 10,000 | — | — | 10,000 | Aug 29, 2019 |
| Bonello William | Chief Strategy Officer | Sale | 17,000 | $24.83 | $422,110 | 6,735 | Aug 28, 2019 |
| JONES STEVEN C | — | Sale | 143,603 | $24.87 | $3,571,407 | 1,748,941 | Aug 27, 2019 |
| HIPP RAYMOND R | — | Sale | 600 | $25.02 | $15,012 | 149,526 | Aug 23, 2019 |
| Johnson Kevin C | — | Sale | 11,800 | $24.74 | $291,932 | 28,285 | Aug 23, 2019 |
| TETRAULT LYNN A. | — | Award / Grant | 3,419 | — | — | 41,653 | Jun 6, 2019 |
| KANOVSKY STEPHEN M | — | Award / Grant | 3,419 | — | — | 3,419 | Jun 6, 2019 |
| Johnson Kevin C | — | Award / Grant | 3,419 | — | — | 81,285 | Jun 6, 2019 |
| CROWTHER BRUCE K | — | Award / Grant | 3,419 | — | — | 36,185 | Jun 6, 2019 |
| HANNAH ALISON L. | — | Award / Grant | 3,419 | — | — | 64,432 | Jun 6, 2019 |
| HIPP RAYMOND R | — | Award / Grant | 3,419 | — | — | 140,999 | Jun 6, 2019 |
| JONES STEVEN C | — | Award / Grant | 3,419 | — | — | 245,234 | Jun 6, 2019 |
| SHOVLIN ROBERT J. | President, Clinical Services | Tax Withholding | 6,559 | — | — | 155,748 | May 25, 2019 |
| VAN OORT DOUGLAS M | Chairman and CEO | Tax Withholding | 25,846 | — | — | 2,066,589 | May 25, 2019 |
| HIPP RAYMOND R | — | Sale | 118,479 | $22.36 | $2,649,190 | 137,580 | May 7, 2019 |
| Bonello William | Chief Strategy Officer | Option Exercise | 7,200 | $7.52 | $54,144 | 13,935 | May 6, 2019 |
| BALLIET JENNIFER | VP and Chief Culture Officer | Sale | 13,333 | $22.74 | $303,192 | 22,862 | May 3, 2019 |
| SHOVLIN ROBERT J. | President, Clinical Services | Sale | 66,667 | $22.14 | $1,476,007 | 162,307 | May 2, 2019 |
| CARDOZA GEORGE | President, Pharma Services | Sale | 151,676 | $22.82 | $3,461,246 | 300,831 | May 2, 2019 |
| VAN OORT DOUGLAS M | Chairman and CEO | Award / Grant | 37,883 | — | — | 2,092,435 | Mar 1, 2019 |
| SHOVLIN ROBERT J. | President, Clinical Services | Award / Grant | 10,944 | — | — | 148,321 | Mar 1, 2019 |
| Virag Sharon | Chief Financial Officer | Award / Grant | 10,944 | — | — | 10,944 | Mar 1, 2019 |
| CARDOZA GEORGE | President, Pharma Services | Award / Grant | 8,418 | — | — | 252,507 | Mar 1, 2019 |
| McKenzie Kathryn B | Principal Accounting Officer | Award / Grant | 2,273 | — | — | 2,273 | Mar 1, 2019 |
| Bonello William | Chief Strategy Officer | Award / Grant | 6,735 | — | — | 6,735 | Mar 1, 2019 |
| Weiss Lawrence Martin | Chief Scientific Officer | Award / Grant | 5,893 | — | — | 5,893 | Mar 1, 2019 |
| BALLIET JENNIFER | VP and Chief Culture Officer | Sale | 14,000 | $19.09 | $267,260 | 22,862 | Feb 28, 2019 |
| CARDOZA GEORGE | President, Pharma Services | Option Exercise | 30,000 | $3.45 | $103,500 | 244,089 | Feb 27, 2019 |
| JONES STEVEN C | Executive Vice President | Sale | 1,900 | $19.27 | $36,613 | 182,371 | Feb 26, 2019 |
| SHOVLIN ROBERT J. | President, Clinical Services | Option Exercise | 119,348 | $7.15 | $853,338 | 242,739 | Feb 26, 2019 |
| Bonello William | Chief Strategy Officer | Sale | 60,203 | $18.90 | $1,137,837 | — | Feb 26, 2019 |
| HIPP RAYMOND R | — | Option Exercise | 3,333 | $7.27 | $24,231 | 306,469 | Feb 26, 2019 |